The Lung Cancer Research Foundation is offering applications for research projects focused on understanding ALK rearrangements as drivers of cancer and developing novel therapeutic approaches for patients with ALK-positive lung cancer. The grant supports research on early progression and metastatic patterns, including understanding why some ALK-positive lung cancers progress more rapidly, investigating leptomeningeal disease, and
Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members: